Replay available

Inspire Medical Systems, Inc. (INSP) Q2 2025 Earnings Call

Inspire Medical Systems, Inc. (NYSE: INSP) Q2 2025 earnings conference call, held 2025-08-04. Replay captured from the company's public earnings webcast.

Mon, August 4, 2025 at 5:00 PMendedReplay
Inspire Medical Systems, Inc. (INSP) Q2 2025 Earnings Call

Investor webinar replay

Latest news releases

Companies on this event

Featured Presenters

Ezgi Yaja

Vice President of Investor Relations

Tim Herbert

Chairman and Chief Executive Officer

Rick Buhols

Chief Financial Officer

Adam Mader

Analyst, Piper Sandler

Travis Speed

Analyst, Bank of America Securities

Danielle Telfie

Analyst, UBS

Robbie Marcus

Analyst, J.P. Morgan

Richard Newiter

Analyst, Truist Securities

David Rescott

Analyst, Baird

Michael Sarconi

Analyst, Jefferies

Shagun Singh

Analyst, RBC

Larry Bigelson

Analyst, Wells Fargo

John Block

Analyst, Stifel

Brett Fishbin

Analyst, KeyBank Capital Markets

Chris Pasquale

Analyst, Nifrin Research

Michael Polark

Analyst, Wolfe Research

Replay transcript excerpt

and I'll be your conference operator today. At this time, I would like to welcome everyone to the INSPIRE Medical Systems second quarter 2025 conference call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there'll be a question and answer session. I'll now hand the call over to your first speaker, Ezgi Yaja, the Vice President of Investor Relations at INSPIRE. You may begin the conference. Thank you, Dalaim, and thank you all for participating in today's call. Joining me are Tim Herbert, Chairman and Chief Executive Officer, and Rick Buhols, Chief Financial Officer. Earlier today, we released financial results for the three months ended June 30, 2025. A copy of the press release is available on our website. On this call, management will make forward-looking statements within the meaning of the federal securities laws. All forward-looking statements including without limitation those relating to our operations, financial results and financial condition, investments in our business, full-year 2025 financial and operational outlook, and changes in market access are based upon our current estimates and various assumptions. These statements involve material risks and uncertainties that could cause actual results or events to materially differ. Accordingly, you should not place undue reliance on these statements. Please see our filings with the Securities and Exchange Commission, including our Form 10-Q, which we filed with the SEC earlier this afternoon, for a description of these risks and uncertainties. INSPIRE disclaims any intention or obligation, except as required by law, to update or revise any financial projections or forward-looking statements, whether because of new information, future events, or otherwise. This...

More from Inspire Medical Systems, Inc.